Regulon

Regulon: R-328

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
191.5600510Pr-143Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
1495 ENSG00000044115 CTNNA1 E5RGS1
9689 ENSG00000082153 BZW1 Q7L1Q6
3655 ENSG00000091409 ITGA6 P23229
3717 ENSG00000096968 JAK2 O60674
5216 ENSG00000108518 PFN1 P07737
5878 ENSG00000108774 RAB5C A0A024R1U4
10728 ENSG00000110958 PTGES3 Q15185
2030 ENSG00000112759 SLC29A1 Q99808
6249 ENSG00000130779 CLIP1 A0A024RBR1
6272 ENSG00000134243 SORT1 Q99523
3936 ENSG00000136167 LCP1 P13796
10097 ENSG00000138071 ACTR2 P61160
9180 ENSG00000145623 OSMR Q99650
55293 ENSG00000151116 UEVLD Q8IX04
6565 ENSG00000163406 SLC15A2 Q16348
5580 ENSG00000163932 PRKCD Q05655
51068 ENSG00000169251 NMD3 Q96D46
5571 ENSG00000181929 PRKAG1 P54619
5660 ENSG00000197746 PSAP P07602

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
RUXOLITINIBJAK1Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor41
MIDOSTAURINKITSmall moleculeINHIBITORVascular endothelial growth factor receptor 2 inhibitor40
PACRITINIBFLT3Small moleculeINHIBITORTyrosine-protein kinase receptor FLT3 inhibitor30
IZENCITINIBJAK1Small moleculeINHIBITORJanus Kinase (JAK) inhibitor20
TOFACITINIBJAK1Small moleculeINHIBITORJanus Kinase (JAK) inhibitor40
GANDOTINIBJAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor20
RUXOLITINIB PHOSPHATEJAK1Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor40
PEFICITINIBJAK1Small moleculeINHIBITORJanus Kinase (JAK) inhibitor30
DIPYRIDAMOLESLC29A1Small moleculeINHIBITOR3',5'-cyclic phosphodiesterase inhibitor40
LESTAURTINIBJAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor30
AC-430JAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor10
MOMELOTINIBJAK1Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor30
NS-018JAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor20
BARICITINIBJAK1Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor40
SOTRASTAURINPRKD3Small moleculeINHIBITORProtein kinase C (PKC) inhibitor20
BMS-911543JAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor20
UPADACITINIBJAK1Small moleculeINHIBITORJanus Kinase (JAK) inhibitor40
FEDRATINIB HYDROCHLORIDEJAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor40
UCN-01CDK4Small moleculeINHIBITOR3-phosphoinositide dependent protein kinase-1 inhibitor20
ZOTIRACICLIBCDK9Small moleculeINHIBITORCyclin-dependent kinase 9 inhibitor11
TOFACITINIB CITRATEJAK1Small moleculeINHIBITORJanus Kinase (JAK) inhibitor40
GUSACITINIBSYKSmall moleculeINHIBITORJanus Kinase (JAK) inhibitor20
XL-019JAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor10
AZD-1480JAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor20
DELGOCITINIBJAK1Small moleculeINHIBITORJanus Kinase (JAK) inhibitor30
AT-9283AURKBSmall moleculeINHIBITORTyrosine-protein kinase JAK3 inhibitor20
DELCASERTIBPRKCDProteinINHIBITORProtein kinase C delta inhibitor20
GSK-690693PRKACBSmall moleculeINHIBITORProtein kinase C (PKC) inhibitor10
FEDRATINIBJAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor40

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-328

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs